advanced cancer diagnostics limited
advanced cancer diagnostics limited Company Information
Company Number
09891926
Next Accounts
Mar 2025
Directors
Shareholders
wojciech janczyk
nick plowman
View AllGroup Structure
View All
Industry
Other human health activities
Registered Address
28 bolton street, london, W1J 8BP
advanced cancer diagnostics limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED CANCER DIAGNOSTICS LIMITED at £84.6k based on a Turnover of £213.8k and 0.4x industry multiple (adjusted for size and gross margin).
advanced cancer diagnostics limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED CANCER DIAGNOSTICS LIMITED at £0 based on an EBITDA of £-11.5k and a 3.05x industry multiple (adjusted for size and gross margin).
advanced cancer diagnostics limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED CANCER DIAGNOSTICS LIMITED at £0 based on Net Assets of £-100.7k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Advanced Cancer Diagnostics Limited Overview
Advanced Cancer Diagnostics Limited is a dissolved company that was located in london, W1J 8BP with a Companies House number of 09891926. It operated in the other human health activities sector, SIC Code 86900. Founded in November 2015, it's largest shareholder was wojciech janczyk with a 72.9% stake. The last turnover for Advanced Cancer Diagnostics Limited was estimated at £213.8k.
Upgrade for unlimited company reports & a free credit check
Advanced Cancer Diagnostics Limited Health Check
Pomanda's financial health check has awarded Advanced Cancer Diagnostics Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
5 Weak
Size
annual sales of £213.8k, make it smaller than the average company (£619k)
- Advanced Cancer Diagnostics Limited
£619k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Advanced Cancer Diagnostics Limited
- - Industry AVG
Production
with a gross margin of 21.3%, this company has a higher cost of product (35.8%)
- Advanced Cancer Diagnostics Limited
35.8% - Industry AVG
Profitability
an operating margin of -5.4% make it less profitable than the average company (6.4%)
- Advanced Cancer Diagnostics Limited
6.4% - Industry AVG
Employees
with 3 employees, this is below the industry average (19)
- Advanced Cancer Diagnostics Limited
19 - Industry AVG
Pay Structure
on an average salary of £22.7k, the company has an equivalent pay structure (£22.7k)
- Advanced Cancer Diagnostics Limited
£22.7k - Industry AVG
Efficiency
resulting in sales per employee of £71.3k, this is more efficient (£41.6k)
- Advanced Cancer Diagnostics Limited
£41.6k - Industry AVG
Debtor Days
it gets paid by customers after 2 days, this is earlier than average (22 days)
- Advanced Cancer Diagnostics Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 221 days, this is slower than average (17 days)
- Advanced Cancer Diagnostics Limited
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Advanced Cancer Diagnostics Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Advanced Cancer Diagnostics Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 8052.1%, this is a higher level of debt than the average (24.8%)
8052.1% - Advanced Cancer Diagnostics Limited
24.8% - Industry AVG
ADVANCED CANCER DIAGNOSTICS LIMITED financials
Advanced Cancer Diagnostics Limited's latest turnover from April 2019 is estimated at £213.8 thousand and the company has net assets of -£100.7 thousand. According to their latest financial statements, we estimate that Advanced Cancer Diagnostics Limited has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2019 | Apr 2018 | Apr 2017 | |
|---|---|---|---|
| Turnover | |||
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | |||
| Interest Receivable | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Dividends Paid | |||
| Retained Profit | |||
| Employee Costs | |||
| Number Of Employees | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2019 | Apr 2018 | Apr 2017 | |
|---|---|---|---|
| Tangible Assets | 1 | 1,356 | 2,713 |
| Intangible Assets | |||
| Investments & Other | |||
| Debtors (Due After 1 year) | |||
| Total Fixed Assets | 1 | 1,356 | 2,713 |
| Stock & work in progress | |||
| Trade Debtors | 1,265 | 11,330 | 12,318 |
| Group Debtors | |||
| Misc Debtors | |||
| Cash | 1,703 | ||
| misc current assets | |||
| total current assets | 1,265 | 11,330 | 14,021 |
| total assets | 1,266 | 12,686 | 16,734 |
| Bank overdraft | |||
| Bank loan | |||
| Trade Creditors | 101,940 | 101,875 | 41,935 |
| Group/Directors Accounts | |||
| other short term finances | |||
| hp & lease commitments | |||
| other current liabilities | |||
| total current liabilities | 101,940 | 101,875 | 41,935 |
| loans | |||
| hp & lease commitments | |||
| Accruals and Deferred Income | |||
| other liabilities | |||
| provisions | |||
| total long term liabilities | |||
| total liabilities | 101,940 | 101,875 | 41,935 |
| net assets | -100,674 | -89,189 | -25,201 |
| total shareholders funds | -100,674 | -89,189 | -25,201 |
| Apr 2019 | Apr 2018 | Apr 2017 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | 1,356 | ||
| Amortisation | |||
| Tax | |||
| Stock | |||
| Debtors | -10,065 | -988 | 12,318 |
| Creditors | 65 | 59,940 | 41,935 |
| Accruals and Deferred Income | |||
| Deferred Taxes & Provisions | |||
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | |||
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | |||
| Group/Directors Accounts | |||
| Other Short Term Loans | |||
| Long term loans | |||
| Hire Purchase and Lease Commitments | |||
| other long term liabilities | |||
| share issue | |||
| interest | |||
| cash flow from financing | |||
| cash and cash equivalents | |||
| cash | -1,703 | 1,703 | |
| overdraft | |||
| change in cash | -1,703 | 1,703 |
advanced cancer diagnostics limited Credit Report and Business Information
Advanced Cancer Diagnostics Limited Competitor Analysis
Perform a competitor analysis for advanced cancer diagnostics limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other undefined companies, companies in W1J area or any other competitors across 12 key performance metrics.
advanced cancer diagnostics limited Ownership
ADVANCED CANCER DIAGNOSTICS LIMITED group structure
Advanced Cancer Diagnostics Limited has no subsidiary companies.
Ultimate parent company
ADVANCED CANCER DIAGNOSTICS LIMITED
09891926
advanced cancer diagnostics limited directors
Advanced Cancer Diagnostics Limited currently has 1 director, Mr Wojciech Janczyk serving since Mar 2017.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Wojciech Janczyk | England | 61 years | Mar 2017 | - | Director |
P&L
April 2019turnover
213.8k
-15%
operating profit
-11.5k
0%
gross margin
21.4%
-4.01%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2019net assets
-100.7k
+0.13%
total assets
1.3k
-0.9%
cash
0
0%
net assets
Total assets minus all liabilities
advanced cancer diagnostics limited company details
company number
09891926
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
November 2015
age
10
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
April 2019
previous names
N/A
accountant
-
auditor
-
address
28 bolton street, london, W1J 8BP
Bank
-
Legal Advisor
-
advanced cancer diagnostics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to advanced cancer diagnostics limited.
advanced cancer diagnostics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ADVANCED CANCER DIAGNOSTICS LIMITED. This can take several minutes, an email will notify you when this has completed.
advanced cancer diagnostics limited Companies House Filings - See Documents
| date | description | view/download |
|---|
